Search research articles
Contact Us
Filters
Showing results (81-90 of 111) with videos related to
Page
of 12
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 25, 2007
Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study
Andrea Gallamini, Martin Hutchings, Luigi Rigacci, et al.
Haematologica
|
September 16, 2017
Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials
Dennis A Eichenauer, Ingrid Becker, Ina Monsef, et al.
Blood
|
March 12, 2010
Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability
Barbara Sarina, Luca Castagna, Lucia Farina, et al.
Hematological Oncology
|
December 19, 2022
Predictive value on advance hodgkin lymphoma treatment outcome of end-of treatment FDG PET/CT in the HD0607 clinical trial
Alberto Biggi, Stephane Chauvie, Federico Fallanca, et al.
British Journal of Haematology
|
December 21, 2010
Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses
Andrea Gallamini, Caterina Patti, Simonetta Viviani, et al.
Leukemia & Lymphoma
|
September 17, 2004
Elevated serum levels of IL-10 are associated with inferior progression-free survival in patients with Hodgkin's disease treated with radiotherapy
Carlo Visco, Theodoros P Vassilakopoulos, Kay Oliver Kliche, et al.
Human Vaccines & Immunotherapeutics
|
October 21, 2022
The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees
Francesca Dapporto, Margherita Leonardi, Claudia Maria Trombetta, et al.
Communications Biology
|
September 2, 2022
Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations
Claudia Maria Trombetta, Giulia Piccini, Giulio Pierleoni, et al.
The New England Journal of Medicine
|
July 22, 2011
ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned
Simonetta Viviani, Pier Luigi Zinzani, Alessandro Rambaldi, et al.
Leukemia & Lymphoma
|
January 2, 2024
High-dose chemotherapy and autologous stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin Lymphoma in the era of PET-adapted strategies
Simonetta Viviani, Anna Vanazzi, Samuele Frassoni, et al.
Page
of 12
Search research articles
Search
Showing results (81-90 of 111) with videos related to
Sort By:
Page
of 12
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 25, 2007
Early interim 2-[18F]fluoro-2-deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma: a report from a joint Italian-Danish study
Andrea Gallamini, Martin Hutchings, Luigi Rigacci, et al.
Haematologica
|
September 16, 2017
Secondary malignant neoplasms, progression-free survival and overall survival in patients treated for Hodgkin lymphoma: a systematic review and meta-analysis of randomized clinical trials
Dennis A Eichenauer, Ingrid Becker, Ina Monsef, et al.
Blood
|
March 12, 2010
Allogeneic transplantation improves the overall and progression-free survival of Hodgkin lymphoma patients relapsing after autologous transplantation: a retrospective study based on the time of HLA typing and donor availability
Barbara Sarina, Luca Castagna, Lucia Farina, et al.
Hematological Oncology
|
December 19, 2022
Predictive value on advance hodgkin lymphoma treatment outcome of end-of treatment FDG PET/CT in the HD0607 clinical trial
Alberto Biggi, Stephane Chauvie, Federico Fallanca, et al.
British Journal of Haematology
|
December 21, 2010
Early chemotherapy intensification with BEACOPP in advanced-stage Hodgkin lymphoma patients with a interim-PET positive after two ABVD courses
Andrea Gallamini, Caterina Patti, Simonetta Viviani, et al.
Leukemia & Lymphoma
|
September 17, 2004
Elevated serum levels of IL-10 are associated with inferior progression-free survival in patients with Hodgkin's disease treated with radiotherapy
Carlo Visco, Theodoros P Vassilakopoulos, Kay Oliver Kliche, et al.
Human Vaccines & Immunotherapeutics
|
October 21, 2022
The neutralizing response to SARS-CoV-2 Omicron variants BA.1 and BA.2 in COVID-19 patients and homologous and heterologous vaccinees
Francesca Dapporto, Margherita Leonardi, Claudia Maria Trombetta, et al.
Communications Biology
|
September 2, 2022
Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations
Claudia Maria Trombetta, Giulia Piccini, Giulio Pierleoni, et al.
The New England Journal of Medicine
|
July 22, 2011
ABVD versus BEACOPP for Hodgkin's lymphoma when high-dose salvage is planned
Simonetta Viviani, Pier Luigi Zinzani, Alessandro Rambaldi, et al.
Leukemia & Lymphoma
|
January 2, 2024
High-dose chemotherapy and autologous stem cell transplant as first salvage treatment for relapsed or refractory Hodgkin Lymphoma in the era of PET-adapted strategies
Simonetta Viviani, Anna Vanazzi, Samuele Frassoni, et al.
Page
of 12